跳至主要内容
临床试验/TCTR20160426004
TCTR20160426004已完成3 期

Effect of the subcutaneous low molecular weight heparin injection technique on bruising and pain

Siriraj Resarch Development Fund0 个研究点目标入组 44 人开始时间: 2016年4月26日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • age 18- 80 y
  • Outpatient who receive Enoxaparin 1 mg/kg twice daily

排除标准

  • -Patients who have mental disorder that affects the brain and perception.
  • -receiving the drug. anticoagulant and antiplatelet addition
  • -Creatinine clearance < 30 ml/mi,Platelet ≤ 100,000 /ul,APTT ≤ 23 or ≥ 32 sec, PT ≤ 11 or ≥ 14 sec
  • -pregnancy or breastfeeding
  • -cann't follow up

研究者

发起方
Siriraj Resarch Development Fund

相似试验

已完成
不适用
Subcutaneously administered low molecular weight heparin for anticoagulation in patients undergoing lung transplantation with periprocedural ECMO support - a retrospective, observational cohort study.lung transplantationextracorporeal membrane oxygenationZ94.2Lung transplant status
DRKS00013593Medizinische Universität WienUniversitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie102
已完成
2 期
Comparative evaluation the effect of preemptive subcutaneous infiltration of two doses of tramadol on post-operative pain of open kidney and urinary tract surgeriespost-operative pain after open urologic surgeries.
IRCT138804222159N1Isfahan University of Medical Sciences96
进行中(未招募)
1 期
Safety and Efficacy of Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Pulmonary Embolism.
EUCTR2015-001830-12-ATniversity Medical Center of the Johannes Gutenberg University Mainz700
进行中(未招募)
1 期
Safety and Efficacy of Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Pulmonary Embolism.Acute Intermediate-Risk Pulmonary EmbolismMedDRA version: 19.0Level: HLTClassification code 10037379Term: Pulmonary embolism and thrombosisSystem Organ Class: 100000004866
EUCTR2015-001830-12-NLniversity Medical Center of the Johannes Gutenberg University Mainz700
进行中(未招募)
1 期
Safety and Efficacy of Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Pulmonary Embolism.Acute Intermediate-Risk Pulmonary EmbolismMedDRA version: 20.0Level: HLTClassification code 10037379Term: Pulmonary embolism and thrombosisSystem Organ Class: 100000004866
EUCTR2015-001830-12-ITIVERSITY MEDICAL SCHOOL OF THE JOHANNES GUTENBERG UNIVERSITY MAINZ530